Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

107.00p
   
  • Change Today:
      3.00p
  • 52 Week High: 109.00
  • 52 Week Low: 80.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 89,685
  • Market Cap: £90.61m
  • RiskGrade: 196

Diaceutics remains 'well positioned' following strong sales performance

By Iain Gilbert

Date: Monday 08 Jul 2019

LONDON (ShareCast) - (Sharecast News) - Data analytics and implementation services firm Diaceutics said on Monday that it had continued to trade in line with market expectations throughout the six months ended 30 June.
Diaceutics said it remained well positioned in key markets, underpinned by a "strong" sales performance.

The AIM-listed group also credited an increased international footprint for enhancing its global offering and allowing the company to acquire new international clients.

The Belfast-based outfit also said its Nexus project, the group's proposed software-as-a-service platform, was "progressing as planned".

Diaceutics, which expects to announce its full interim results in early September, said all outstanding debts had now been "retired" from its balance sheet, resulting in net cash of £14m.

As of 1010 BST, Diaceutics shares were up 2.96% at 87p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 107.00p
Change Today 3.00p
% Change 2.88 %
52 Week High 109.00
52 Week Low 80.50
Volume 89,685
Shares Issued 84.68m
Market Cap £90.61m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.87% below the market average90.87% below the market average90.87% below the market average90.87% below the market average90.87% below the market average
81.25% below the sector average81.25% below the sector average81.25% below the sector average81.25% below the sector average81.25% below the sector average
Price Trend
45.03% above the market average45.03% above the market average45.03% above the market average45.03% above the market average45.03% above the market average
56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average
Income Not Available
Growth
2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Diaceutics Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:35 457 @ 107.00p
16:35 457 @ 107.00p
13:37 18,918 @ 104.50p
14:00 82 @ 104.00p
14:00 82 @ 104.00p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page